PTC THERAPEUTICS, INC.

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income (Loss) Attributable to Parent ($142.1m) ($79.0m) ($128.1m) ($251.6m) ($438.2m) ($523.9m) ($559.0m) ($626.6m) ($363.3m) $682.6m
Net Income (Loss) Available to Common Stockholders, Basic ($142.1m) ($79.0m) ($128.1m) ($251.6m) ($438.2m) ($523.9m) ($559.0m) ($626.6m) ($363.3m) $682.6m
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest ($142.1m)
Depreciation, Depletion and Amortization $3.3m $17.7m $26.1m $32.2m $43.5m $64.1m $128.8m $236.6m $75.7m $38.8m
Depreciation $3.3m $2.3m $2.6m $4.7m $6.6m $9.4m $12.3m $13.9m $14.9m $14.2m
Amortization of Debt Issuance Costs $302k $433k $524k $694k $1.0m $1.8m $1.9m $1.9m $1.2m $1.2m
Amortization of Intangible Assets $15.4m $22.9m $27.6m $36.9m $54.8m $116.6m $222.6m $60.7m $24.7m
Deferred Income Tax Expense (Benefit) ($199k) $199k $0 $8.8m $5.9m $377k ($34.3m) ($46.9m) ($55.9m) ($3k)
Share-based Payment Arrangement, Noncash Expense $35.0m $30.6m $33.3m $42.1m $70.3m $103.5m $110.3m $101.6m $74.6m $74.5m
Share-based Payment Arrangement, Expense $35.0m $30.6m $33.3m $42.1m $70.3m $103.5m $110.3m $101.6m $74.6m $74.5m
Goodwill, Impairment Loss $0 $0 $0 $0 $0 $0
Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) $0 $0 $33.4m $217.8m $159.5m
Gain (Loss) on Disposition of Assets $0 ($5k) ($2k) ($312k) ($16k) ($80k) ($806k)
Gain (Loss) on Disposition of Other Assets ($345k) ($163k)
Gain (Loss) on Disposition of Property Plant Equipment ($4.3m) ($130k)
Gain (Loss) on Extinguishment of Debt ($137.6m)
Income Tax Expense (Benefit) $569k $1.3m ($29k) $11.7m $35.2m $5.6m ($28.5m) ($69.5m) $176k $14.0m
Operating Lease, Expense $2.7m $6.0m $15.3m $21.4m $25.2m $29.0m $24.9m $21.1m
Other Nonoperating Income (Expense) ($1.2m) ($1.3m) $129k $13.7m $85.2m ($57.9m) ($49.2m) $10.1m $6.5m ($18.1m)
Changes in operating assets and liabilities:
Additional Financial Items
Increase (Decrease) in Inventories $6.5m $5.8m $3.5m ($1.8m) ($1.8m) $6.7m $8.2m ($6.2m) $53.9m
Proceeds from Stock Options Exercised $968k $2.2m $10.9m $18.3m $70.2m $17.3m $14.6m $24.0m $28.6m $93.1m
Debt Securities, Available-for-sale, Realized Gain (Loss) ($622k)
Equity Securities, FV-NI, Realized Gain (Loss) $4.4m
Equity Securities, FV-NI, Unrealized Gain (Loss) ($2.2m) $14.3m $1.7m ($8.0m) $2.5m $2.6m $4.0m
Foreign Currency Transaction Gain (Loss), Realized $1.2m ($459k) ($59k) ($11.6m) ($57.0m) $47.4m ($16.9m) ($14.1m) ($10.4m) $3.4m
Foreign Currency Transaction Gain (Loss), Unrealized ($1.2m) $459k $59k $11.6m $57.0m ($47.4m) ($13.3m) $14.1m $10.4m ($3.4m)
Gain (Loss) on Termination of Lease $2.2m
General and Administrative Expense $97.1m $121.3m
Goodwill $82.3m $82.3m $82.3m $82.3m $82.3m $82.3m $82.3m $82.3m
Inventory Write-down $1.8m $400k $500k $2.2m $1.7m $12.5m $13.2m $5.2m
Operating Expenses $214.8m $258.7m $380.4m $548.1m $812.5m $913.0m $1.1b $1.4b $1.1b $863.7m
Revenue from Contract with Customer, Including Assessed Tax $264.7m $307.0m
Unrealized Gain (Loss) on Investments $2.2m ($14.3m) $6.1m $3.6m $1.5m ($7.7m) ($5.7m)
Net Cash Provided by (Used in) Operating Activities ($103.6m) ($10.1m) ($27.6m) ($98.6m) ($194.1m) ($251.3m) ($356.7m) ($158.4m) ($107.7m) $711.2m
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment $1.8m $3.1m $7.1m $13.8m $17.8m $28.2m $32.0m $28.4m $6.5m $8.9m
Payments to Acquire Businesses, Net of Cash Acquired $48.9m $0
Net Cash Provided by (Used in) Investing Activities $104.5m $13.1m ($42.6m) ($387.2m) ($561.5m) $219.2m $290.2m ($176.7m) $44.2m ($862.0m)
Cash flows from financing activities:
Repayments of Long-term Debt $0
Proceeds from Issuance of Common Stock $0 $117.9m $323.8m $28.1m
Net Cash Provided by (Used in) Financing Activities $968k $44.2m $131.6m $613.2m $668.7m $20.9m $168.0m $646.4m $255.9m $331.1m
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents ($1.6m) $6.2m ($3.6m) ($1.3m) $7.7m ($7.8m) ($2.8m) $3.1m ($7.3m) $22.7m
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect ($1.6m) $6.2m ($3.6m) $126.0m ($79.2m) ($19.1m) $98.7m $314.4m $185.0m $203.0m
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $111.8m $169.5m $295.5m $216.3m $197.2m $295.9m $610.3m $795.3m $998.3m
Supplemental disclosure of cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating Activities $4.5m $6.3m $7.8m $7.7m $9.8m $9.6m $18.5m $36.1m $5.8m $5.7m
Income Taxes Paid, Net $943k $1.1m $1.6m $2.1m $26.4m $7.7m $4.9m $14.2m $17.6m $36.9m

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.